SILVER SPRING, Md., Aug. 29, 2011 /PRNewswire-USNewswire/ -- Science, public health, and regulatory highlights from the U.S. Food and Drug Administration. Information in this document is designed for credentialed journalists. Release dates and times for items are current as of August 29, 2011.
(Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO)
FDA News & Notes does not contain any regulatory or enforcement actions due to legal limitations.
Events and Speeches for the Commissioner and FDA leadership:
Thursday, 9/8 – FDA Commissioner Margaret Hamburg, M.D., delivers keynote remarks titled "Reducing Risk Through Effective Policy and Public Health Practice," at the conference on 9/11 + 10: Science, Policy, and Public Health; Looking Ahead to the Next 10 Years in New York. 10:15 a.m., Columbia University, Low Memorial Library, 535 West 116th Street, New York City.
Columbia University Contacts: Stephanie Berger, [email protected], 212-305-4372 Claudia Willis, [email protected], 212-305-8044
Press Office Contact: Raymond Formanek Jr., [email protected], 301-796-4677
Meetings, Workshops and Congressional Testimony:
Tuesday, 8/30 – The General and Plastic Surgery Devices Panel will make recommendations on postmarketing issues related to silicone gel-filled breast implants during a two-day meeting. 8 a.m., Hilton Washington D.C. North/Gaithersburg, 620 Perry Pkwy., Ballroom, Gaithersburg, Md.
Press Office Contact: Erica Jefferson, 301-796-4988, [email protected]
Thursday, 9/8 – The Obstetrics and Gynecology Devices Panel of the Medical Devices Advisory Committee holds a two-day meeting to make recommendations on the safety and effectiveness of transvaginal surgical mesh used for repair of pelvic organ prolapse. 8 a.m., Holiday Inn, 2 Montgomery Village Ave., Ballroom, Gaithersburg, Md.
Press Office Contact: Karen Riley, 301-796-4674, [email protected]
Friday, 9/9 – The Reproductive Health Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee discuss the benefits and risks of long-term bisphosphonate use for the treatment and prevention of osteoporosis. 8 a.m., Marriott Inn and Conference Center, University of Maryland University College, 3501 University Blvd. East, Adelphi, Md.
Press Office Contact Jeff Ventura at 301-796-2807, [email protected]
On the Web:
Classification of the Eyelid Thermal Pulsation System
Press Office Contact: Karen Riley, 301-796-4674; [email protected]
FDA Office of Public Affairs Contact Information:
Call or email FDA Office of Public Affairs, 301-796-4540, [email protected]
List of FDA press officers and beats
More Resources:
FDA News and Events
FDA Photos (Flickr)
Consumer Health Information
SOURCE U.S. Food and Drug Administration
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article